» Articles » PMID: 29380234

Exploring the Current and Future Role of the Pharmacists in Osteoporosis Screening and Management in Malaysia

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2018 Jan 31
PMID 29380234
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background Several studies have found that pharmacists can assist in screening and prevention of osteoporosis by referring patients for bone mineral density scans and counselling on lifestyle changes. In Malaysia, screening osteoporosis in all elderly women is not mandatory due to its cost. One approach to address this gap is to develop a pharmacist-led osteoporosis screening and prevention program. However, there is a paucity of data on the perspectives of Malaysian pharmacists in this area. Objective To explore the perspective of stakeholders (policy makers, doctors, pharmacists, nurses and patients) towards the role of pharmacists in osteoporosis screening and management. Setting A primary care clinic located within a teaching hospital in Kuala Lumpur, Malaysia. Method Patients (n = 20), nurses (n = 10), pharmacists (n = 11), doctors (n = 10) and policy makers (n = 5) were individually interviewed using a semi-structured topic guide. Purposive sampling was used. Interviews were transcribed verbatim and analysed using thematic analysis. Main outcome measure Perspective of stakeholders on the current and future role of pharmacists. Results All participants perceived pharmacists to be suppliers of medication, although there was some recognition of roles in providing medication advice. Nonetheless, these stakeholders were eager for pharmacists to expand their non-dispensing roles towards counselling, creating awareness and screening of osteoporosis. Interviewed pharmacists referred to their current role as 'robotic dispensers' and unanimously agreed to spread out to osteoporosis management role. Conclusion Under stakeholders there is a willingness to expand the role of pharmacists in Malaysia to non-dispensing roles, particularly in osteoporosis screening and management.

Citing Articles

Healthcare professionals' perspectives and experiences of osteoporosis medication treatment: a qualitative systematic review.

Rezae F, Kelly A, Dey S, Moles R, Carter S Arch Osteoporos. 2024; 19(1):8.

PMID: 38191760 DOI: 10.1007/s11657-023-01359-y.


Screening and Diagnosing Osteoporosis Among Postmenopausal Women in Primary Care Settings in Malaysia: A Systematic Review.

Chin W, Chu E, Chiang R Maedica (Bucur). 2022; 17(2):492-504.

PMID: 36032605 PMC: 9375864. DOI: 10.26574/maedica.2022.17.2.492.

References
1.
Lee E, Wong P, Tan M, Sheridan J . What role could community pharmacists in Malaysia play in diabetes self-management education and support? The views of individuals with type 2 diabetes. Int J Pharm Pract. 2017; 26(2):138-147. DOI: 10.1111/ijpp.12374. View

2.
Iversen L, Mollison J, MacLeod T . Attitudes of the general public to the expanding role of community pharmacists: a pilot study. Fam Pract. 2001; 18(5):534-6. DOI: 10.1093/fampra/18.5.534. View

3.
Yuksel N, Majumdar S, Biggs C, Tsuyuki R . Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int. 2009; 21(3):391-8. DOI: 10.1007/s00198-009-0977-z. View

4.
McDonough R, Doucette W, Kumbera P, Klepser D . An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health. 2005; 8(1):24-31. DOI: 10.1111/j.1524-4733.2005.04007.x. View

5.
Chen H, Boore J . Translation and back-translation in qualitative nursing research: methodological review. J Clin Nurs. 2009; 19(1-2):234-9. DOI: 10.1111/j.1365-2702.2009.02896.x. View